Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 137

  • Showing results for woo, hyun kim. Search instead for Wook-Hyung Kim (0)
1.

Conversion of Glycosylated Platycoside E to Deapiose-Xylosylated Platycodin D by Cytolase PCL5.

Shin KC, Kim DW, Woo HS, Oh DK, Kim YS.

Int J Mol Sci. 2020 Feb 11;21(4). pii: E1207. doi: 10.3390/ijms21041207.

2.

Inhibitory Effects of β-Caryophyllene on Helicobacter pylori Infection In Vitro and In Vivo.

Woo HJ, Yang JY, Lee MH, Kim HW, Kwon HJ, Park M, Kim SK, Park SY, Kim SH, Kim JB.

Int J Mol Sci. 2020 Feb 3;21(3). pii: E1008. doi: 10.3390/ijms21031008.

3.
4.

Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-label randomized trial.

Kim SJ, Chung JW, Woo HS, Kim SY, Kim JH, Kim YJ, Kim KO, Kwon KA, Park DK.

World J Gastroenterol. 2019 Dec 14;25(46):6790-6798. doi: 10.3748/wjg.v25.i46.6790.

5.

Peroxiredoxin III Protects Tumor Suppressor PTEN from Oxidation by 15-Hydroperoxy-eicosatetraenoic Acid.

Zhang Y, Park J, Han SJ, Lim Y, Park I, Kim JS, Woo HA, Lee SR.

Oxid Med Cell Longev. 2019 Sep 15;2019:2828493. doi: 10.1155/2019/2828493. eCollection 2019.

6.

Constituents of the leaves and twigs of Elaeagnus umbellata and their proliferative effects on human keratinocyte HaCaT cells.

Paudel SB, Park J, Kim NH, Choi H, Seo EK, Woo HA, Nam JW.

Fitoterapia. 2019 Nov;139:104374. doi: 10.1016/j.fitote.2019.104374. Epub 2019 Oct 17.

PMID:
31629867
7.

Primary epiploic appendagitis: compared with diverticulitis and focused on obesity and recurrence.

Choi YI, Woo HS, Chung JW, Shim YS, Kwon KA, Kim KO, Kim YJ, Park DK.

Intest Res. 2019 Oct;17(4):554-560. doi: 10.5217/ir.2018.00148. Epub 2019 Oct 14.

8.

EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.

Yoon S, Choi JH, Kim SJ, Lee EJ, Shah M, Choi S, Woo HG.

Exp Mol Med. 2019 Jun 3;51(6):1-12. doi: 10.1038/s12276-019-0261-z.

9.

Refeeding Syndrome as a Possible Cause of Very Early Mortality in Acute Pancreatitis.

Jeon TJ, Lee KJ, Woo HS, Kim EJ, Kim YS, Park JY, Cho JH.

Gut Liver. 2019 Sep 15;13(5):576-581. doi: 10.5009/gnl18458.

10.

Early experience with Watson for oncology in Korean patients with colorectal cancer.

Kim EJ, Woo HS, Cho JH, Sym SJ, Baek JH, Lee WS, Kwon KA, Kim KO, Chung JW, Park DK, Kim YJ.

PLoS One. 2019 Mar 25;14(3):e0213640. doi: 10.1371/journal.pone.0213640. eCollection 2019.

11.

RNAi Screening-based Identification of USP10 as a Novel Regulator of Paraptosis.

Kim JY, Lee DM, Woo HG, Kim KD, Lee HJ, Kwon YJ, Choi KS.

Sci Rep. 2019 Mar 20;9(1):4909. doi: 10.1038/s41598-019-40982-z.

12.

The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2.

Han SY, Woo HY, Heo J, Park SG, Pyeon SI, Park YJ, Kim DU, Kim GH, Kim HH, Song GA, Cho M.

Korean J Intern Med. 2019 Mar 19. doi: 10.3904/kjim.2018.329. [Epub ahead of print]

13.

Inhibitory Effects of Menadione on Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation via NF-κB Inhibition.

Lee MH, Yang JY, Cho Y, Woo HJ, Kwon HJ, Kim DH, Park M, Moon C, Yeon MJ, Kim HW, Seo WD, Kim SH, Kim JB.

Int J Mol Sci. 2019 Mar 7;20(5). pii: E1169. doi: 10.3390/ijms20051169.

14.

Local delivery of a cancer-favoring oncolytic vaccinia virus via poly (lactic-co-glycolic acid) nanofiber for theranostic purposes.

Badrinath N, Jeong YI, Woo HY, Bang SY, Kim C, Heo J, Kang DH, Yoo SY.

Int J Pharm. 2018 Dec 1;552(1-2):437-442. doi: 10.1016/j.ijpharm.2018.10.020. Epub 2018 Oct 9.

PMID:
30308276
15.

Anti-inflammatory effects of Kaempferol on Helicobacter pylori-induced inflammation.

Yeon MJ, Lee MH, Kim DH, Yang JY, Woo HJ, Kwon HJ, Moon C, Kim SH, Kim JB.

Biosci Biotechnol Biochem. 2019 Jan;83(1):166-173. doi: 10.1080/09168451.2018.1528140. Epub 2018 Oct 5.

PMID:
30286691
16.

Embryonic Stem Cell-Derived mmu-miR-291a-3p Inhibits Cellular Senescence in Human Dermal Fibroblasts Through the TGF-β Receptor 2 Pathway.

Bae YU, Son Y, Kim CH, Kim KS, Hyun SH, Woo HG, Jee BA, Choi JH, Sung HK, Choi HC, Park SY, Bae JH, Doh KO, Kim JR.

J Gerontol A Biol Sci Med Sci. 2019 Aug 16;74(9):1359-1367. doi: 10.1093/gerona/gly208.

PMID:
30239625
17.

Peroxiredoxin5 Controls Vertebrate Ciliogenesis by Modulating Mitochondrial Reactive Oxygen Species.

Ji Y, Chae S, Lee HK, Park I, Kim C, Ismail T, Kim Y, Park JW, Kwon OS, Kang BS, Lee DS, Bae JS, Kim SH, Moon PG, Baek MC, Park MJ, Kil IS, Rhee SG, Kim J, Huh YH, Shin JY, Min KJ, Kwon TK, Jang DG, Woo HA, Kwon T, Park TJ, Lee HS.

Antioxid Redox Signal. 2019 May 10;30(14):1731-1745. doi: 10.1089/ars.2018.7507. Epub 2018 Oct 30.

PMID:
30191719
18.

Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B.

Kim TH, Lee EJ, Choi JH, Yim SY, Lee S, Kang J, Lee YR, Lee HA, Choi HS, Kim ES, Keum B, Seo YS, Yim HJ, Jeen YT, Chun HJ, Lee HS, Kim CD, Woo HG, Um SH.

PLoS One. 2018 Jul 5;13(7):e0199094. doi: 10.1371/journal.pone.0199094. eCollection 2018.

19.

Peroxiredoxin 5 regulates adipogenesis-attenuating oxidative stress in obese mouse models induced by a high-fat diet.

Kim MH, Park SJ, Kim JH, Seong JB, Kim KM, Woo HA, Lee DS.

Free Radic Biol Med. 2018 Aug 1;123:27-38. doi: 10.1016/j.freeradbiomed.2018.05.061. Epub 2018 May 16.

PMID:
29777756
20.

Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis.

Jang JW, Choi JY, Kim YS, Yoo JJ, Woo HY, Choi SK, Jun CH, Lee CH, Sohn JH, Tak WY, Lee YR, Han KH.

Clin Gastroenterol Hepatol. 2018 Dec;16(12):1954-1963.e3. doi: 10.1016/j.cgh.2018.04.063. Epub 2018 May 9.

PMID:
29753085

Supplemental Content

Loading ...
Support Center